RASCHI, EMANUEL

RASCHI, EMANUEL  

DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Docenti di ruolo di IIa fascia  

Mostra records
Risultati 1 - 20 di 218 (tempo di esecuzione: 0.049 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S....; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E. 2025-01-01 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista Donati etal. EurJCliniPharm 2025.pdf228_2025_3852_MOESM1_ESM.docx
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure Armillotta, Matteo; Angeli, Francesco; Paolisso, Pasquale; Belmonte, Marta; Raschi, Emanuel; Di D...almazi, Guido; Amicone, Sara; Canton, Lisa; Fedele, Damiano; Suma, Nicole; Foà, Alberto; Bergamaschi, Luca; Pizzi, Carmine 2025-01-01 PHARMACOLOGY & THERAPEUTICS - 1.01 Articolo in rivista armill SGLT2i.pdf
Comment on “evaluation of anticancer therapy-related dermatologic adverse events: insight from Food and Drug Administration’s adverse event reporting system dataset”. Raschi, E; La Placa, M; Starace, M. 2025-01-01 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY - 1.04 Replica / breve intervento (e simili) -
Safety of Hydroxychloroquine: What a Dermatologist Should Know Rapparini, Luca; Cedirian, Stephano; La Placa, Michelangelo; Piraccini, Bianca Maria; Raschi, Ema...nuel; Starace, Michela 2025-01-01 AMERICAN JOURNAL OF CLINICAL DERMATOLOGY - 1.01 Articolo in rivista 40257_2025_Article_919.pdf
The interface of depression and diabetes: treatment considerations Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C. 2025-01-01 TRANSLATIONAL PSYCHIATRY - 1.01 Articolo in rivista Fanelli et al. Translational psychiatry 2025.pdf
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista Lunghi et al. Drug Safety 2024.pdf40264_2024_1453_MOESM1_ESM.pdf
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database De Filippis, R.; Kane, J. M.; Arzenton, E.; Moretti, U.; Raschi, E.; Trifiro, G.; Barbui, C.; De ...Fazio, P.; Gastaldon, C.; Schoretsanitis, G. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista DRESS Antipsychotics Vigibase DS.pdfDRESS Antipsychotics Vigibase DS Suppl.pdf
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality Schoretsanitis, G.; Weiler, S.; Barbui, C.; Raschi, E.; Gastaldon, C. 2024-01-01 JAMA NETWORK OPEN - 1.01 Articolo in rivista GLP-1 suicidality JAMA Network Open.pdfGLP-1 suicidality JAMA Network Open suppl.pdf
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Rasch...i, E. 2024-01-01 TARGETED ONCOLOGY - 1.01 Articolo in rivista -
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-023-01391-4.pdf40264_2023_1391_MOESM1_ESM.docx
Environmental sustainability-an essential component of rational use of medicines Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; N...ekoro, M 2024-01-01 INTERNATIONAL JOURNAL OF PHARMACY PRACTICE - 1.01 Articolo in rivista -
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. 2024-01-01 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E. 2024-01-01 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY - 1.01 Articolo in rivista -
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Jos...hi, N.; Khouri, C. 2024-01-01 DRUG SAFETY - 1.04 Replica / breve intervento (e simili) -
Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase Noseda, R.; Bedussi, F.; Giunchi, V.; Fusaroli, M.; Raschi, E.; Ceschi, A. 2024-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista e009902.full.pdf
Symmetrical cutaneous rash in two women. Orioni G, Velez-Pelaez MC, Starace MVR, Tengattini V, Raschi E, La Placa M. 2024-01-01 CLINICAL CASE REPORTS - 1.01 Articolo in rivista Clinical Case Reports - 2024 - Orioni.pdf
The evolving role of disproportionality analysis in pharmacovigilance Fusaroli, M.; Raschi, E.; Poluzzi, E.; Hauben, M. 2024-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-024-01421-9.pdf40264_2024_1421_MOESM1_ESM.pdf
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-024-01423-7 (1).pdf
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline Fusaroli, M.; Salvo, F.; Khouri, C.; Raschi, E. 2024-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista fphar-15-1488725.pdfData Sheet 1.PDF